-+ 0.00%
-+ 0.00%
-+ 0.00%

Verrica Pharmaceuticals shareholders approve amended 2018 equity incentive plan at annual meeting

PUBT·06/09/2026 20:06:42
Listen to the news
Verrica Pharmaceuticals shareholders approve amended 2018 equity incentive plan at annual meeting
  • Verrica Pharmaceuticals held its annual shareholder meeting on June 5, 2026.
  • Shareholders adopted an amended and restated 2018 Equity Incentive Plan, effective immediately upon approval.
  • Shareholders ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders elected two director nominees to serve until the 2029 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-263722), on June 09, 2026, and is solely responsible for the information contained therein.